National HealthCare Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für National HealthCare zu prognostizieren.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Healthcare Gewinnwachstum	20.1%
Wachstumsrate der Einnahmen	n/a
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	None
Zuletzt aktualisiert	n/a

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

Why We Think National HealthCare Corporation's (NYSEMKT:NHC) CEO Compensation Is Not Excessive At All

May 01

Returns On Capital At National HealthCare (NYSEMKT:NHC) Paint A Concerning Picture

Apr 09

Is National HealthCare Corporation (NYSEMKT:NHC) A Good Fit For Your Dividend Portfolio?

Mar 17

National HealthCare Corporation's (NYSEMKT:NHC) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?

Mar 02

National HealthCare Corporation (NYSEMKT:NHC) Insiders Have Been Selling

Feb 15

Reflecting on National HealthCare's (NYSEMKT:NHC) Share Price Returns Over The Last Year

Feb 02

Could The National HealthCare Corporation (NYSEMKT:NHC) Ownership Structure Tell Us Something Useful?

Jan 20

These Metrics Don't Make National HealthCare (NYSEMKT:NHC) Look Too Strong

Jan 07

Do These 3 Checks Before Buying National HealthCare Corporation (NYSEMKT:NHC) For Its Upcoming Dividend

Dec 25

What We Learned About National HealthCare's (NYSEMKT:NHC) CEO Pay

Dec 24

Is National HealthCare Corporation's (NYSEMKT:NHC) 3.1% Dividend Worth Your Time?

Dec 12

Does National HealthCare Corporation's (NYSEMKT:NHC) Weak Fundamentals Mean A Downturn In Its Stock Should Be Expected?

Nov 30

In diesem Abschnitt stellen wir normalerweise Umsatz- und Gewinnwachstumsprognosen vor, die auf den Konsensschätzungen professioneller Analysten basieren, um den Anlegern zu helfen, die Fähigkeit des Unternehmens zur Gewinnerzielung zu verstehen. Da National HealthCare jedoch nicht genügend Daten aus der Vergangenheit zur Verfügung gestellt hat und keine Analystenprognose vorliegt, können die zukünftigen Erträge nicht zuverlässig durch Extrapolation von Vergangenheitsdaten oder anhand von Analystenprognosen berechnet werden.

Dies ist eine recht seltene Situation, da 97 % der von SimplyWall St erfassten Unternehmen über Finanzdaten aus der Vergangenheit verfügen.

Gewinn- und Umsatzwachstumsprognosen

NYSEAM:NHC - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
6/30/2024	1,172	92	89	118	N/A
3/31/2024	1,163	81	80	107	N/A
12/31/2023	1,135	67	83	111	N/A
9/30/2023	1,105	45	72	97	N/A
6/30/2023	1,087	32	37	63	N/A
3/31/2023	1,075	19	22	50	N/A
12/31/2022	1,074	22	-21	9	N/A
9/30/2022	1,079	32	-26	12	N/A
6/30/2022	1,074	31	-22	21	N/A
3/31/2022	1,051	133	-22	22	N/A
12/31/2021	1,011	139	23	62	N/A
9/30/2021	989	150	36	66	N/A
6/30/2021	961	167	66	89	N/A
3/31/2021	950	90	189	208	N/A
12/31/2020	978	42	181	203	N/A
9/30/2020	985	28	185	209	N/A
6/30/2020	994	35	191	216	N/A
3/31/2020	1,004	20	69	96	N/A
12/31/2019	996	68	74	100	N/A
9/30/2019	990	73	70	96	N/A
6/30/2019	989	74	60	88	N/A
3/31/2019	984	83	68	97	N/A
12/31/2018	979	59	69	98	N/A
9/30/2018	977	62	70	101	N/A
6/30/2018	972	52	72	104	N/A
3/31/2018	968	41	N/A	95	N/A
12/31/2017	964	56	N/A	94	N/A
9/30/2017	956	49	N/A	97	N/A
6/30/2017	947	48	N/A	85	N/A
3/31/2017	936	50	N/A	80	N/A
12/31/2016	924	51	N/A	91	N/A
9/30/2016	923	51	N/A	85	N/A
6/30/2016	917	51	N/A	90	N/A
3/31/2016	914	49	N/A	83	N/A
12/31/2015	907	46	N/A	83	N/A
9/30/2015	899	44	N/A	81	N/A
6/30/2015	892	45	N/A	89	N/A
3/31/2015	884	45	N/A	85	N/A
12/31/2014	872	45	N/A	82	N/A
9/30/2014	852	46	N/A	70	N/A
6/30/2014	830	54	N/A	82	N/A
3/31/2014	805	55	N/A	93	N/A
12/31/2013	789	56	N/A	102	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von NHC über der Sparquote liegt (2.5%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von NHC schneller wachsen werden als der Markt US

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von NHC in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von NHC schneller wachsen werden als der Markt von US.

Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von NHC schneller wachsen werden als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von NHC in 3 Jahren voraussichtlich hoch sein wird

National HealthCare Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Upcoming dividend of US$0.61 per share

Senior VP & CFO recently sold US$260k worth of stock

CEO & Director recently sold US$494k worth of stock

Independent Chairman exercised options to buy US$389k worth of stock.

Second quarter dividend of US$0.61 announced

Second quarter 2024 earnings released: EPS: US$1.74 (vs US$1.06 in 2Q 2023)

National Healthcare Corporation Announces Quarterly Dividend, Payable on November 1, 2024

Upcoming dividend of US$0.61 per share

First quarter dividend increased to US$0.61

National Healthcare Corporation Declares Quarterly Dividend, Payable on August 1, 2024

First quarter 2024 earnings released: EPS: US$1.71 (vs US$0.76 in 1Q 2023)

Independent Director exercised options to buy US$420k worth of stock.

National HealthCare Corporation, Annual General Meeting, May 09, 2024

Upcoming dividend of US$0.59 per share

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: US$4.36 (vs US$1.46 in FY 2022)

Third quarter dividend of US$0.59 announced

NHC Announces Quarterly Common Dividend, Payable on May 1, 2024

Independent Director exercised options to buy US$312k worth of stock.

Upcoming dividend of US$0.59 per share at 2.5% yield

Independent Chairman exercised options to buy US$290k worth of stock.

Independent Director recently sold US$641k worth of stock

Third quarter 2023 earnings released: EPS: US$0.68 (vs US$0.16 loss in 3Q 2022)

National Healthcare Corporation Announces Quarterly Dividend, Payable on February 1, 2024

Independent Director exercised options to buy US$131k worth of stock.

Upcoming dividend of US$0.59 per share at 3.5% yield

Independent Chairman recently bought US$131k worth of stock

New major risk - Revenue and earnings growth

Second quarter 2023 earnings released: EPS: US$1.06 (vs US$0.21 in 2Q 2022)

National Healthcare Corporation Announces Quarterly Dividend, Payable on November 1, 2023

Independent Director recently bought US$129k worth of stock

Upcoming dividend of US$0.59 per share at 3.9% yield

Independent Director recently bought US$135k worth of stock

National HealthCare Corporation Announces Quarterly Dividend, Payable on July 31, 2023

First quarter 2023 earnings released: EPS: US$0.76 (vs US$0.99 in 1Q 2022)

Upcoming dividend of US$0.57 per share at 4.1% yield

Independent Director recently bought US$125k worth of stock

Full year 2022 earnings released: EPS: US$1.46 (vs US$9.03 in FY 2021)

National Healthcare Corporation Declares Quarterly Dividend, Payable on May 1, 2023

Upcoming dividend of US$0.57 per share

Independent Director exercised options to buy US$106k worth of stock.

Independent Director recently sold US$211k worth of stock

Insufficient new directors

National HealthCare Corporation Announces Quarterly Dividend, Payable on February 1, 2023

Third quarter 2022 earnings released: US$0.16 loss per share (vs US$0.22 loss in 3Q 2021)

Upcoming dividend of US$0.57 per share

Independent Director exercised options to buy US$175k worth of stock.

National HealthCare Corporation (NYSEAM:NHC) announces an Equity Buyback for $25 million worth of its shares.

Second quarter 2022 earnings released: EPS: US$0.21 (vs US$6.83 in 2Q 2021)

National Healthcare Corporation Announces Quarterly Dividend, Payable on November 1, 2022

Upcoming dividend of US$0.57 per share

Independent Chairman exercised options to buy US$135k worth of stock.

Independent Director exercised options to buy US$529k worth of stock.

First quarter 2022 earnings released: EPS: US$0.99 (vs US$1.39 in 1Q 2021)

National Healthcare Corporation Announces Quarterly Dividend, Payable on August 1, 2022

Insufficient new directors

Upcoming dividend of US$0.55 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

National Healthcare Corporation Announces Quarterly Dividend, Payable on May 2, 2022

National HealthCare Corporation Appoints Sandra Y. Trail to Its Board of Director, Effective February 1, 2022

Independent Director exercised options to buy US$350k worth of stock.

Upcoming dividend of US$0.55 per share

CEO & Director exercised options and sold US$132k worth of stock

Third quarter 2021 earnings released: US$0.22 loss per share (vs US$0.84 profit in 3Q 2020)

Upcoming dividend of US$0.52 per share

Second quarter 2021 earnings released: EPS US$6.83 (vs US$1.85 in 2Q 2020)

Upcoming dividend of US$0.52 per share

Independent Director exercised options to buy US$567k worth of stock.

First quarter 2021 earnings released: EPS US$1.39 (vs US$1.76 loss in 1Q 2020)

National Healthcare Corporation Announces Quarterly Dividend, Payable on August 2, 2021

Independent Director exercised options to buy US$527k worth of stock.

Why We Think National HealthCare Corporation's (NYSEMKT:NHC) CEO Compensation Is Not Excessive At All

Returns On Capital At National HealthCare (NYSEMKT:NHC) Paint A Concerning Picture

Upcoming Dividend of US$0.52 Per Share

Independent Director recently sold US$151k worth of stock